Clinical Trials Update: Nov. 30, 2004
(HealthDayNews) — Here are the latest clinical trials, courtesy of CenterWatch:
A research study evaluating patient satisfaction with a once-monthly pill for the treatment and prevention of osteoporosis. Volunteers who have been taking weekly medication for the prevention of postmenopausal osteoporosis for at least three months may be eligible. Research site located in Clearwater, Fla.
Please see http://www.centerwatch.com/patient/studies/cat111.html.
A research study testing whether insulin glargine and omega-3 fatty acids can prevent future cardiovascular disease and associated complications. Volunteers 50 or older who have any of these risk factors may be eligible: a blood-sugar level that is slightly high, type 2 diabetes treated by a maximum of one pill, a previous heart attack or stroke, stable or unstable angina, or other diseases of the heart or blood vessels. Research site located in Los Angeles, Calif.
Please see http://www.centerwatch.com/patient/studies/cat213.html.
A research study of an investigational medication for dyspepsia. Volunteers 18 or older who have active dyspepsia symptoms may be eligible to participate in this 9-week study. Research site located in Dallas, TX.
Please see http://www.centerwatch.com/patient/studies/cat310.html.
Copyright 2004 CenterWatch. All rights reserved.